Navigation Links
CRH Medical Corporation opens center in New Orleans, Louisiana
Date:7/8/2008

VANCOUVER, July 8 /PRNewswire-FirstCall/ - CRH Medical Corporation (CRM:TSX-V) announced today that it has opened a Center for Colorectal Health in New Orleans, Louisiana. This Center is the Company's first center in the state of Louisiana, one of many new markets that CRH has targeted for expansion. The opening of this location represents the 8th new Center opened in 2008 bringing the Company's total number of Centers to 16.

According to the National Institute of Health, the prevalence rate of hemorrhoids in the US is about 4.4% of the population. Approximately 50% of the U.S. population will develop hemorrhoids by age 50. The Company plans to significantly increase the number of Centers for Colorectal Health across the U.S. to address this underserved market.

About CRH Medical Corporation:

CRH Medical Corporation specializes in the treatment of hemorrhoids utilizing its proven treatment protocol and patented proprietary technology. CRH's single use, disposable, hemorrhoid technology is safe and highly effective in treating hemorrhoid grades I - IV. CRH Medical employs two commercialization strategies: First, it operates Centers for Colorectal Health facilities in the United States specializing in the treatment of hemorrhoids and fissures, and colon cancer screening. In addition CRH distributes its hemorrhoid banding technology, treatment protocols, operational and marketing expertise as a complete, "turn key" package directly to its partner physicians. The Company's goal is to establish the CRH hemorrhoid technology as the standard for hemorrhoid treatment.

The information in this news release contains so-called "forward-looking" statements. These include statements regarding CRH Medical expectations, beliefs, intentions or strategies for the future, which may be indicated by words or phrases such as "anticipate", "expect", "intend", "plan", "will", "we believe", "CRH Medical believes", "management believes" and similar language. All forward-looking statements are based on CRH Medical current expectations and are subject to risks and uncertainties and to assumptions made.

The TSX Venture Exchange does not accept responsibility for the adequacy

or accuracy of this release.

CONTACT: call Dean Linden, Investor Relations, CRH Medical Corporation at (604) 633-1440 or ir@crhmedcorp.com. Additional information may also be found by visiting the Company's website at http://www.crhmedcorp.com or the SEDAR website at http://www.sedar.com.


'/>"/>
SOURCE CRH Medical Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Mitigating Medical Identity Theft: AHIMA Journal Provides Patient Tools to Secure Health Information
2. Southern Home Medical Reports Its Encore Medical Staffing Division Increases Revenues by 63%
3. Central Bucks Specialists, a Cardiology and Gastroenterology Multi-location Clinic, Selects MxSecure, Inc., Provider of Medical Transcription Services, as their Transcription Provider.
4. Baron & Budd Attorney Denyse Clancy Speaks at International Mesothelioma Programs First Annual Harvard Medical School Course
5. Cleveland Clinic Physicians to Present at Medical Conference in Panama, July 11-12
6. HealthSouth To Acquire Rehabilitation Unit at Medical Center of Arlington
7. Blue Cross and Blue Shield of Georgia and Athens Regional Medical Center Announce New HMO/POS Contract
8. The Peer Group Launches Xpert Xchange(SM), an Innovation in Medical Peer Influence Programs
9. ATS Medical Expects Second Quarter Revenue of $16.7 to $16.9 Million
10. Pennsylvania Medical Society and AARP Criticize Senator Specter for Blocking Bill to Protect Access to Doctors and Improve Medicare
11. AARP, Texas Medical Association Join Forces to Urge Passage of Bill Protecting Access to Doctors and Improving Medicare
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... ... 24, 2017 , ... HealthPostures, expert standing desk solution designer, ... built into the home office sit stand solution are bold colors, a new ... the benefits embedded in the TaskMate Go are available 24/7 through HealthPostures' online ...
(Date:2/24/2017)... ... February 24, 2017 , ... Only two months after the official release of ... in Cannes (France), XO Private has initiated a second print-run of its lavish luxury ... a metre across when open, weighs in at more than six kilos, retails at ...
(Date:2/24/2017)... ... , ... An in-depth computational analysis of genetic variants implicated in both schizophrenia ... that may explain why susceptibility to one of the disorders could place individuals at ... in the journal npj Schizophrenia. , “There is a wealth of genomic data ...
(Date:2/24/2017)... ... ... The Smart Machine Age is here, and it’s disrupting everything. Not only could it ... the United States may be taken over by technology in the next five to ... over colleagues is drawing to a close. Success will belong to those who can ...
(Date:2/24/2017)... ... February 24, 2017 , ... With ... is so critically important that we all are aware of our options and ... is proud to announce the launch of its newest edition of "Vision and ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... -- Research and Markets has announced the addition of ... report to their offering. ... The latest research Urinary Incontinence Drugs Price Analysis ... the global Urinary Incontinence market. The research answers the following ... marketed for Urinary Incontinence and their clinical attributes? How are they ...
(Date:2/23/2017)...  Cogentix Medical, Inc. (NASDAQ: CGNT), a medical device ... for the urology market, will release financial results for ... 2016 before the market open on Thursday, March 9, ... conference call and webcast to discuss its financial results ... 11:00 a.m. Eastern Time (10:00 a.m. Central Time). ...
(Date:2/23/2017)... -- Research and Markets has announced the addition of ... report to their offering. ... The latest research Oesophageal Cancer Drugs Price Analysis ... the global Oesophageal Cancer market. The research answers the ... drugs marketed for Oesophageal Cancer and their clinical attributes? How are ...
Breaking Medicine Technology: